APREPITANT |
APREPITANT : Antagonist of TACR1
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| TACR1 |
|
|
Antagonist
up to 10 nM
Selectivity
In Vitro Selectivity Assessment
Potency Assay Off-Target:
Selectivity within target family (DOI: 10.1016/S0028-3908(99)00172-0)
hNK2 IC50 4500 nM
hNK3 IC50 30 ...
Potency Cellular
In Vitro
TACR1
Mode of Action: Antagonist
Structure-Activity-Relationship data available? No
DOI Reference: 10.1021/jm980299k
In Vivo Validations
Ferret
Dose: 0.1-3.0 mg/Kg
Route of delivery:
Intravenous
Target engagement assay:
ID90 0.3 mg/Kg
DOI Reference: 10.1021/jm980299k
Rat
Dose: 2 and 5 mg/Kg
Route of delivery:
Intravenous
Area Under the Curve::
2700 ± 340, 6400 ± 1200 mg*h/mL
DOI Reference: 10.1021/jm990617v
Dog
Dose: 0.5, 2.0 mg/Kg
Route of delivery:
Intravenous
Area Under the Curve::
3800 ± 1100 38000 ± 8000 mg*h/mL
DOI Reference: 10.1021/jm990617v
Chemical Information
| Molecular Formula | C23H21F7N4O3 |
| SMILEs | C[C@@H](O[C@H]1OCCN(Cc2n[nH]c(=O)[nH]2)[C@H]1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1 |
| InChI | InChI=1S/C23H21F7N4O3/c1-12(14-8-15(22(25,26)27)10-16(9-14)23(28,29)30)37-20-19(13-2-4-17(24)5-3-13)34(6-7-36-20)11-18-31-21(35)33-32-18/h2-5,8-10,12,19-20H,6-7,11H2,1H3,(H2,31,32,33,35)/t12-,19+,20-/m1/s1 |
| Molecular weight | 534.15 Da |
| AlogP | 4.9521 |
| HBond acceptors | 7 |
| HBond donors | 2 |
| Atoms | 58 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.